Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Harrison

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|May 10, 2011
Part 2: Design, synthesis and evaluation of hydroxyproline-derived α2δ ligandsDavid J Rawson, Delphine Brugier, Anthony Harrison, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 15, 2025
Augmenting trauma-focused cognitive behavior therapy for post-traumatic stress disorder with memory specificity training: a randomized controlled trialRichard A Bryant, Katie S Dawson, Srishti Yadav, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 14, 2011
Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigmsAnthony Harrison, Iain Gardner, Tanya Hay, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stabilityPatrick S Johnson, Thomas Ryckmans, Justin Bryans, et al.
Journal of Medicinal Chemistry|January 8, 2015
Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseasesGeorg Jaeschke, Sabine Kolczewski, Will Spooren, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|May 10, 2011
Part 2: Design, synthesis and evaluation of hydroxyproline-derived α2δ ligandsDavid J Rawson, Delphine Brugier, Anthony Harrison, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 15, 2025
Augmenting trauma-focused cognitive behavior therapy for post-traumatic stress disorder with memory specificity training: a randomized controlled trialRichard A Bryant, Katie S Dawson, Srishti Yadav, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 14, 2011
Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigmsAnthony Harrison, Iain Gardner, Tanya Hay, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stabilityPatrick S Johnson, Thomas Ryckmans, Justin Bryans, et al.
Journal of Medicinal Chemistry|January 8, 2015
Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseasesGeorg Jaeschke, Sabine Kolczewski, Will Spooren, et al.
Pageof 4